Brian Anderson
Principal and Consulting Actuary
San Diego, CA, US
Brian is a consultant with the San Diego office of Milliman. He joined the firm in 2008, and has been a pharmacy benefits consultant since 2001.
Experience
Brian has provided pharmacy benefit consulting services to a wide range of clients, including Medicare plans, Medicaid MCOs, VA, health plans, state systems, union funds, coalitions, high-risk pools, PBMs, GPOs, and large employers. His consulting specialty is the prescription drug benefit market. His experience includes understanding prescription benefit operations, pharmacy benefit manager contracting, cost management, program development, and yearly benefit planning. He has demonstrated success in prescription benefit management, strategic planning, and problem solving, and has a successful track record of overall cost management, with an emphasis on practical and focused solutions.
Brian's experience includes:
- Healthcare reform
- Management of Medicare and Medicaid programs
- Auditing
- Contracting
- Vendor selection
- Benefit planning
- Benefit operations management
- Vendor oversight
- Benefit design
- Cost analysis
Publications and Presentations
Presentations
- IFEBP Annual Conference
- NCPERS Annual Conference
- World Congress Executive Forum on PBM Strategies
- National Healthcare Reform Conference
- ISCEBS Employee Benefits Symposium
Publications
- Medicare Part D: Optimizing the Opportunities for Employer Plans (IFEBP, Benefits and Compensation Digest, Volume 46, No. 4, Feb. 2009)
- Medicare Part D: Taking another look at employee group waiver plans for tax-exempt plan sponsors (Milliman briefing paper, 2009)
- Effective contracting with Pharmacy Benefit Managers: Protecting a plan sponsor's resources (Society of Actuaries, Health Watch, Issue 63 Feb. 2010)
- Healthcare reform and Medicare Part D: Closing the donut hole-and more (Milliman briefing paper, 2010)
- Healthcare reform and pharmacy benefits: Changes in benefits and reporting requirements (Milliman briefing paper, 2010)
- Law of Averages: New benchmarks for wholesale drug pricing have the health industry scrambling to adapt (A.M. Best, Best's Review, May 2010)
- Coming to Grips with Reform and its Impact on Drug Coverage. (InsuranceNewsNet Magazine, August 2010)
Education
- MBA, University of Phoenix
- BA, Biology and Health-related Areas, Columbia College
Affiliations
- National Council of Prescription Drug Plans (NCPDP)
- Member, IFEBP
Publications
Read their latest work
Article
Pharmacy Briefing | March 2025
11 March 2025 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the key pharmacy highlights from March, including FDA approvals and launches, and industry developments.
Article
Pharmacy Briefing | November 2024
20 November 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the key pharmacy highlights from November , including FDA approvals and launches, and industry developments.
Article
Pharmacy Briefing | July 2024
14 August 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail key pharmacy news from July, including FDA approvals and launches and industry developments.
Article
Commercial drug trends: 2024 release
24 July 2024 - by Brian Anderson, Rebekah Bayram, Andrew Dressler, Marc Guieb, Niharika Tarimela, Jason Mui
Pharmacy benefits costs continue to rise year over year, driven by a variety of factors such as novel treatments, consumer demand, and federal legislation.
Article
Pharmacy Briefing | May 2024
17 June 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, including FDA approvals and launches, and industry developments.
Article
Pharmacy Briefing | February 2024
20 February 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, trends, and insights, including FDA approvals and launches, clinical trials, and industry developments.
Article
Pharmacy Briefing | October 2023
22 November 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, trends, and insights, including FDA approvals and launches, clinical trials, and industry developments.
Article
Commercial Drug Trends: 2023 release
13 October 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb, Niharika Tarimela, Andrew Dressler
Average wholesale drug prices per member will increase 11% to 19% among commercial health plans from 2022 to 2024, according to our analysis of pharmaceutical spending trends.
Article
Pharmacy Briefing | July 2023
29 August 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, trends, and insights, including FDA approvals and launches, clinical trials, and industry developments.
Article
Pharmacy Briefing | May 2023
27 June 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest on pharmacy news, trends, and insights, including items on the company and state levels, FDA approvals and launches, and clinical trials.